Search

everythinglearnresearchcommunity

for

Search:↓

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

People with atopic dermatitis have different skin bacteria, and targeting these bacteria might help treat the condition.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Scarless healing is complex and influenced by genetics and environment, while better understanding could improve scar treatment.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Bioengineered scaffolds help heal skin wounds, but perfect treatments are still needed.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

The scalp's microorganisms significantly affect hair health and disease.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Advances in mechanobiology and immunology could lead to scarless wound healing.

Vitamin D and its receptor are essential for hair growth, cell regulation, immune function, and heart health.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Newborn skin is uniquely prepared to adapt to new environments compared to adult skin.

ILC1-like cells can independently cause alopecia areata.

Chitosan–hydroxyapatite biocomposites are promising for tissue engineering due to their safety and ability to support healing.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

Exosomes show promise in skin and hair treatments, but more research is needed to ensure their safety and effectiveness.

Neuroregulation is crucial for skin wound healing and can be targeted to improve recovery.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

A new mouse model for vitiligo helps study immune responses and potential treatments.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

Gut bacteria may influence hair loss in alopecia areata.